Literature DB >> 8741147

Wilson's disease: resolution of MRI lesions following long-term oral zinc therapy.

C C Huang1, N S Chu.   

Abstract

A 28-year-old man with Wilson's disease developed neurological deterioration after a low-dose of d-penicillamine treatment for 2 weeks. He showed an akinetic rigid syndrome with generalized dystonia. Brain magnetic resonance images (MRI) on T2 and proton weighted images showed an increased signal intensity over the thalamus, basal ganglia and brainstem, especially the midbrain and pons. After treatment had been changed to zinc sulphate, the akinetic-rigid syndrome and dystonia were improved slowly in the following 4 years. Serial MRI studies showed a gradual resolution of the lesions. His current neurological status was almost normal except for dysarthria and mild intention tremor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8741147     DOI: 10.1111/j.1600-0404.1996.tb00203.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

Review 1.  ACP Best Practice No 163. Wilson's disease: acute and presymptomatic laboratory diagnosis and monitoring.

Authors:  D Gaffney; G S Fell; D S O'Reilly
Journal:  J Clin Pathol       Date:  2000-11       Impact factor: 3.411

2.  MR imaging of the brain in Wilson disease of childhood: findings before and after treatment with clinical correlation.

Authors:  T J Kim; I O Kim; W S Kim; J E Cheon; S G Moon; J W Kwon; J K Seo; K M Yeon
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

Review 3.  Decreased T2 signal in the thalami may be a sign of lysosomal storage disease.

Authors:  Taina Autti; Raimo Joensuu; Laura Aberg
Journal:  Neuroradiology       Date:  2007-03-03       Impact factor: 2.804

4.  Wilson's disease: two treatment modalities. Correlations to pretreatment and posttreatment brain MRI.

Authors:  Maria do Desterro Leiros da Costa; Mariana Spitz; Luiz Alberto Bacheschi; Claudia Costa Leite; Leandro Tavares Lucato; Egberto Reis Barbosa
Journal:  Neuroradiology       Date:  2009-05-29       Impact factor: 2.804

5.  Six-year clinical and MRI quantitative susceptibility mapping (QSM) follow-up in neurological Wilson's disease under zinc therapy: a case report.

Authors:  D Zaino; I Chiarotti; C Battisti; S Salvatore; A Federico; A Cerase
Journal:  Neurol Sci       Date:  2018-09-13       Impact factor: 3.307

6.  Resolved Psychosis after Liver Transplantation in a Patient with Wilson's Disease.

Authors:  Orazio Sorbello; Daniela Riccio; Margherita Sini; Mauro Carta; Luigi Demelia
Journal:  Clin Pract Epidemiol Ment Health       Date:  2011-12-30

7.  Reversible lesions in the brain parenchyma in Wilson's disease confirmed by magnetic resonance imaging: earlier administration of chelating therapy can reduce the damage to the brain.

Authors:  Duško B Kozić; Igor Petrović; Marina Svetel; Tatjana Pekmezović; Aleksandar Ragaji; Vladimir S Kostić
Journal:  Neural Regen Res       Date:  2014-11-01       Impact factor: 5.135

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.